Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12236 | 857 | 44.5 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1588 | 6626 | FIBROBLAST GROWTH FACTOR//KERATINOCYTE GROWTH FACTOR//SPROUTY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FRS3 | Author keyword | 21 | 85% | 1% | 11 |
2 | FRS2 | Author keyword | 16 | 60% | 2% | 18 |
3 | FGFRL1 | Author keyword | 12 | 75% | 1% | 9 |
4 | FGFR | Author keyword | 11 | 21% | 5% | 45 |
5 | FGFR4 | Author keyword | 10 | 34% | 3% | 24 |
6 | FIBROBLAST GROWTH FACTOR RECEPTOR 4 | Author keyword | 9 | 50% | 2% | 13 |
7 | FIBROBLAST GROWTH FACTOR RECEPTOR | Author keyword | 7 | 15% | 5% | 46 |
8 | FIBROBLAST GROWTH FACTOR RECEPTOR 1 | Author keyword | 7 | 27% | 3% | 23 |
9 | DOVITINIB | Author keyword | 7 | 41% | 2% | 13 |
10 | FGFR1 | Author keyword | 6 | 17% | 4% | 32 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FRS3 | 21 | 85% | 1% | 11 | Search FRS3 | Search FRS3 |
2 | FRS2 | 16 | 60% | 2% | 18 | Search FRS2 | Search FRS2 |
3 | FGFRL1 | 12 | 75% | 1% | 9 | Search FGFRL1 | Search FGFRL1 |
4 | FGFR | 11 | 21% | 5% | 45 | Search FGFR | Search FGFR |
5 | FGFR4 | 10 | 34% | 3% | 24 | Search FGFR4 | Search FGFR4 |
6 | FIBROBLAST GROWTH FACTOR RECEPTOR 4 | 9 | 50% | 2% | 13 | Search FIBROBLAST+GROWTH+FACTOR+RECEPTOR+4 | Search FIBROBLAST+GROWTH+FACTOR+RECEPTOR+4 |
7 | FIBROBLAST GROWTH FACTOR RECEPTOR | 7 | 15% | 5% | 46 | Search FIBROBLAST+GROWTH+FACTOR+RECEPTOR | Search FIBROBLAST+GROWTH+FACTOR+RECEPTOR |
8 | FIBROBLAST GROWTH FACTOR RECEPTOR 1 | 7 | 27% | 3% | 23 | Search FIBROBLAST+GROWTH+FACTOR+RECEPTOR+1 | Search FIBROBLAST+GROWTH+FACTOR+RECEPTOR+1 |
9 | DOVITINIB | 7 | 41% | 2% | 13 | Search DOVITINIB | Search DOVITINIB |
10 | FGFR1 | 6 | 17% | 4% | 32 | Search FGFR1 | Search FGFR1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ARG388 ALLELE | 117 | 93% | 5% | 43 |
2 | GLY388ARG POLYMORPHISM | 44 | 100% | 2% | 16 |
3 | FGFR1 AMPLIFICATION | 23 | 86% | 1% | 12 |
4 | FGFR4 GLY388ARG POLYMORPHISM | 17 | 79% | 1% | 11 |
5 | FGFR4 ARG388 ALLELE | 13 | 67% | 1% | 12 |
6 | NVP BGJ398 | 12 | 86% | 1% | 6 |
7 | DOCKING PROTEIN FRS2 ALPHA | 12 | 47% | 2% | 18 |
8 | K SAM | 9 | 43% | 2% | 16 |
9 | FRS2 FAMILY | 9 | 83% | 1% | 5 |
10 | HUMAN FGF8 | 9 | 83% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
FGFR1 amplification in lung squamous cell carcinoma: A systematic review with meta-analysis | 2015 | 4 | 36 | 69% |
Fibroblast growth factor signalling: from development to cancer | 2010 | 555 | 172 | 31% |
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors | 2014 | 26 | 94 | 61% |
Fibroblast growth factor receptors: multifactorial-contributors to tumor initiation and progression | 2015 | 3 | 195 | 39% |
FGF Receptors: Cancer Biology and Therapeutics | 2014 | 40 | 153 | 27% |
Fibroblast growth factors and their receptors in cancer | 2011 | 132 | 182 | 36% |
Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives | 2013 | 47 | 82 | 51% |
Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction | 2015 | 2 | 121 | 40% |
Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations | 2014 | 14 | 100 | 41% |
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins | 2008 | 72 | 57 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC BIOL NUTR | 5 | 23% | 2.2% | 19 |
2 | TRANSLAT CANC GENOM | 4 | 50% | 0.7% | 6 |
3 | SYST BIOMED TECHNOL | 2 | 27% | 0.9% | 8 |
4 | EARLY CANDIDATE | 2 | 67% | 0.2% | 2 |
5 | NEURAL SIGNALING | 2 | 27% | 0.8% | 7 |
6 | FRANCE SERV ANAT PATHOL | 1 | 100% | 0.2% | 2 |
7 | STOMACH SOFT TISSUE SARCOMA SURG | 1 | 50% | 0.2% | 2 |
8 | LUNG CANC BIOL GRP | 1 | 33% | 0.4% | 3 |
9 | LUNGENKLIN MERHEIM | 1 | 25% | 0.5% | 4 |
10 | MAS UNIV HOSP | 1 | 20% | 0.6% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196686 | FIBROBLAST GROWTH FACTOR//FGF RECEPTOR//UNCONVENTIONAL PROTEIN SECRETION |
2 | 0.0000190995 | ZNF703//C8ORF4//8P12 |
3 | 0.0000185142 | KERATINOCYTE GROWTH FACTOR//KGF//KERATINOCYTE GROWTH FACTOR RECEPTOR |
4 | 0.0000178571 | FGF 21//FIBROBLAST GROWTH FACTOR 21//BETA KLOTHO |
5 | 0.0000164479 | SPROUTY//SPRED//SPROUTY 2 |
6 | 0.0000074055 | DIARYLAMIDE//VEGFR 2 INHIBITOR//KDR KINASE |
7 | 0.0000065636 | ACHONDROPLASIA//HYPOCHONDROPLASIA//THANATOPHORIC DYSPLASIA |
8 | 0.0000059165 | NKX31//LOBUND//3 2 DIMETHYL 4 AMINOBIPHENYL |
9 | 0.0000057520 | CHEK2//PALB2//SERV CIRUGIA GEN ESPECIALIDADES |
10 | 0.0000057211 | SHIONOGI CARCINOMA 115//VITAMIN B 12B//CLIN EXPT PATHOPHYSIOL |